Company Filing History:
Years Active: 2010-2020
Title: The Innovations of Karl Hanf
Introduction
Karl Hanf is a notable inventor based in Billerica, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of 4 patents, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Among his latest patents, Hanf has developed Anti-GPIIB/IIIA antibodies and their uses. These antibodies specifically bind to glycoprotein IIb/IIIa (GPIIb/IIIa) and include chimeric molecules that comprise such antibodies or antigen-binding fragments. The methods of using these antibodies, antibody fragments, and chimeric molecules are aimed at targeting agents to platelets and treating or preventing various diseases or disorders. Another significant patent is for Anti-CD154 antibodies, which provides peptides and fragments that include at least one amino acid substitution compared to the wild type 5c8 antibody. This invention also encompasses compositions and methods for treating CD154-related diseases or disorders in subjects.
Career Highlights
Hanf has worked with prominent companies in the biotechnology sector, including Biogen Idec MA Inc. and Biogen MA Inc. His work in these organizations has contributed to significant advancements in medical treatments and therapies.
Collaborations
Throughout his career, Hanf has collaborated with esteemed colleagues such as Alexey Alexandrovich Lugovskoy and Herman Van Vlijmen. These collaborations have further enriched his research and development efforts.
Conclusion
Karl Hanf's innovative contributions to biotechnology, particularly through his patents, highlight his role as a significant inventor in the field. His work continues to impact medical science and improve treatment options for various diseases.